Accuray, Inc.

  • Can This Robot Doctor Heal Itself?

    By Leo Sun - July 12, 2013 | Tickers: ARAY, ISRG, MAKO | Editor's Choice

    Shares of surgical robot maker Intuitive Surgical (NASDAQ: ISRG) plunged 16% on July 9, after the Sunnyvale, Calif.-based company warned that its second quarter revenue would come in below analyst estimates when it reports earnings on July 18.

    It’s been a chaotic year for Intuitive Surgical, which produces the da Vinci surgical robot that was once the darling of Wall Street. Despite rising 2,700% over the past more »

  • Is Intuitive Surgical Cheap After the Recent Plunge?

    By Anh HOANG - July 11, 2013 | Tickers: ARAY, ISRG, MDT

    Recently, Intuitive Surgical (NASDAQ: ISRG) experienced a significant decline of more than 11.3% in after-hours trading, from $500 per share to only $443.50 per share. The dramatic fall was due to its disappointing outlook for its second quarter results. Should investors consider this recent significant drop a buying opportunity? Let’s take a closer look and find out.

    Fast and consistent operating performance growth

    Intuitive Surgical is the more »

  • What Is Missed on Intuitive Surgical's Big Miss

    By Dana Blankenhorn - July 11, 2013 | Tickers: ARAY, ISRG, MAKO | Editor's Choice

    Investors got little warning on Intuitive Surgical's (NASDAQ: ISRG) big second quarter miss. The first most heard about it might have been the company's own press release – the company doesn't officially report until next week.

    In practical terms the miss isn't much – revenue of $575 million against an expected $630 million, and net income of $160 million instead of $177.7 million. But the stock, which more »

  • Another Strong Year Ahead for This Well Run Company

    By Lee Samaha - February 4, 2013 | Tickers: ARAY, COV, ROP, VAR

    Another good set of results at Roper Industries (NYSE: ROP), and the company continues to execute superbly within a strong set of end markets. I think there is some upside from its key growth drivers in 2013, and Roper will need it because the stock is approaching full value. With that said, this is a very well run company, and for those willing to take a long term view it more »

  • A SWOT Analysis of This Long Term Growth Play

    By Lee Samaha - January 22, 2013 | Tickers: ARAY, ISRG, SI, VAR

    Varian Medical Systems (NYSE: VAR) offers an attractive long term picture but it also contains some execution risk. In fact, its mix of profit drivers and stock specific risk are so rich and diverse that probably the best way to start looking at it would be via a SWOT analysis. In summary, there are many reasons to like the stock but there are also risks. I think this stock will more »

  • 2012 Robotic Stocks Wrap-up

    By Frank Tobe - January 7, 2013 | Tickers: ABB, ARAY, ISRG, IRBT, MAKO | Editor's Choice

    By Frank Tobe, Editor and Publisher, The Robot Report

    If an enterprising firm set up a mutual fund reflecting the worldwide robotics industry, they might choose to separate their picks into three segments, which might look something like this:

    1. Industrial Robot Manufacturers
    2. Service Robot Makers of security, defense and space robots
    3. Service Robot Makers of robots for all other purposes

    Although I am neither a broker nor an analyst, I more »

  • Passport Special Situation Pick: Accuray

    By Meena Krishnamsetty - March 22, 2012 | Tickers: ARAY, ISRG, MAKO, SI, VAR

    Passport Special Opportunities Fund is coming off a disappointing fourth quarter - it was down -5.5% net versus 7.3% for the MSCI AC World Index and 11.8% for the S&P 500. Since inception in May 2008, the Fund has compounded at 9.7% net on an annualized basis. Over the same period, the MSCI AC World has compounded at -4.0% and the S&P 500 at more »

  • J.P. Morgan Healthcare Conference Schedule: Day One

    By Brandy Betz - January 8, 2012 | Tickers: ARAY, ACOR, A, ALGN, AMRN, AMGN, AMLN, ARTC, BIIB, BMRN, BRKR, CFN, CTRX, CELG, CNC, COV, DNDN, XRAY, EW, ENDP, EPOC, ESRX, GHDX, GILD, HLS, HTWR, HMSY, HGSI, IDXX, IPXL, INCY, IRWD, MCK, MRX, MDT, MR, MOH, MYL, NVS, ONXX, PRX, PRGO, QSII, REGN, RMD, RIGL, SGEN, ST, SIAL, THC, MDCO, THOR, VRTX, VVUS, WAT, WMGI, ZLTQ

    The 30th Annual J.P. Morgan Healthcare Conference kicks off with a full day of presentations from companies that range from global pharmaceutical leaders to small cap novel pharmaceutical developers and health technology manufacturers. The majority of the presentations will be available through live webcasts with archived replay offered later in the day.

    I will be following (and covering) the novel therapeutic companies that have caught my eye. VIVUS (NASDAQ: VVUSmore »)